Daniel V. Veres

Daniel V. Veres

Auto-generated profile, based on publicly available information

Daniel V. Veres

Turbine Simulated Cell Technologies, Budapest, Hungary

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2014 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
DVDaniel V. Veres
Daniel V. Veres
DGDávid M. Gyurkó
Dávid M. Gyurkó
BTBenedek Thaler
Benedek Thaler
KSKristóf Z. Szalay
Kristóf Z. Szalay
DFDavid Fazekas
David Fazekas
PCPeter Csermely
Peter Csermely
Here we present ComPPI, a cellular compartment-specific database of proteins and their interactions enabling an extensive, compartmentalized protein–protein interaction network analysis (URL: http://ComPPI.LinkGroup.hu). ComPPI enables the user to filter biologically unlikely interactions, where the two interacting proteins have no common subcellular localizations and to predict novel properties, such as compartment-specific biological functions. ComPPI is an integrated database covering four species (S. cerevisiae, C. elegans, D. melanogaster and H. sapiens). The compilation of nine protein–protein interaction and eight subcellular localization data sets had four curation steps including a manually built, comprehensive hierarchical structure of >1600 subcellular localizations. ComPPI provides confidence scores for protein subcellular localizations and protein–protein interactions. ComPPI has user-friendly search options for individual proteins giving their subcellular localization, their interactions and the likelihood of their interactions considering the subcellular localization of their interacting partners. Download options of search results, whole-proteomes, organelle-specific interactomes and subcellular localization data are available on its website. Due to its novel features, ComPPI is useful for the analysis of experimental results in biochemistry and molecular biology, as well as for proteome-wide studies in bioinformatics and network science helping cellular biology, medicine and drug design.

1 February 2015 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
PCPeter Csermely
Peter Csermely
JHJános Hódsági
János Hódsági
TKTamás Korcsmáros
Tamás Korcsmáros
DMDezső Módos
Dezső Módos
ÁPÁron R. Perez-Lopez
Áron R. Perez-Lopez
XZXiang-Sun Zhang
Xiang-Sun Zhang

1 February 2012 in Current Protein & Peptide Science
Verified
Journal Article
Open access
PDF file
PCPeter Csermely
Peter Csermely
KSKuljeet Singh Sandhu
Kuljeet Singh Sandhu
EHEszter Hazai
Eszter Hazai
ZHZsolt Hoksza
Zsolt Hoksza
HKHuba J.M. Kiss
Huba J.M. Kiss
RNRuth Nussinov
Ruth Nussinov
During the last decade, network approaches became a powerful tool to describe protein structure and dynamics. Here we review the links between disordered proteins and the associated networks, and describe the consequences of local, mesoscopic and global network disorder on changes in protein structure and dynamics. We introduce a new classification of protein networks into ‘cumulus-type’, i.e., those similar to puffy (white) clouds, and ‘stratus-type’, i.e., those similar to flat, dense (dark) low-lying clouds, and relate these network types to protein disorder dynamics and to differences in energy transmission processes. In the first class, there is limited overlap between the modules, which implies higher rigidity of the individual units; there the conformational changes can be described by an ‘energy transfer’ mechanism. In the second class, the topology presents a compact structure with significant overlap between the modules; there the conformational changes can be described by ‘multi-trajectories’; that is, multiple highly populated pathways. We further propose that disordered protein regions evolved to help other protein segments reach ‘rarely visited’ but functionally-related states. We also show the role of disorder in ‘spatial games’ of amino acids; highlight the effects of intrinsically disordered proteins (IDPs) on cellular networks and list some possible studies linking protein disorder and protein structure networks

1 August 2013 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
DGDávid M. Gyurkó
Dávid M. Gyurkó
DVDániel V. Veres
Dániel V. Veres
DMDezső Módos
Dezső Módos
KLKatalin Lenti
Katalin Lenti
TKTamás Korcsmáros
Tamás Korcsmáros
PCPeter Csermely
Peter Csermely

1 January 2009 in Genome Medicine
Verified
Journal Article
Open access
PDF file
GSGábor I Simkó
Gábor I Simkó
DGDávid Gyurkó
Dávid Gyurkó
DVDániel V Veres
Dániel V Veres
TNTibor Nánási
Tibor Nánási
PCPeter Csermely
Peter Csermely
Recent studies have demonstrated that network approaches are highly appropriate tools for understanding the extreme complexity of the aging process. Moreover, the generality of the network concept helps to define and study the aging of technological and social networks and ecosystems, which may generate novel concepts for curing age-related diseases. The current review focuses on the role of protein-protein interaction networks (inter-actomes) in aging. Hubs and inter-modular elements of both interactomes and signaling networks are key regulators of the aging process. Aging induces an increase in the permeability of several cellular compartments, such as the cell nucleus, introducing gross changes in the representation of network structures. The large overlap between aging genes and genes of age-related major diseases makes drugs that aid healthy aging promising candidates for the prevention and treatment of age-related diseases, such as cancer, atherosclerosis, diabetes and neurodegenerative disorders. We also discuss a number of possible research options to further explore the potential of the network concept in this important field, and show that multi-target drugs (representing 'magic-buckshots' instead of the traditional 'magic bullets') may become an especially useful class of age-related drugs in the future.

21 June 2024 in npj Systems Biology and Applications
Verified
Journal Article
Open access
PDF file
OPOrsolya Papp
Orsolya Papp
VJViktória Jordán
Viktória Jordán
SHSzabolcs Hetey
Szabolcs Hetey
RBRóbert Balázs
Róbert Balázs
VKValér Kaszás
Valér Kaszás
DVDaniel V. Veres
Daniel V. Veres
Combination therapy is well established as a key intervention strategy for cancer treatment, with the potential to overcome monotherapy resistance and deliver a more durable efficacy. However, given the scale of unexplored potential target space and the resulting combinatorial explosion, identifying efficacious drug combinations is a critical unmet need that is still evolving. In this paper, we demonstrate a network biology-driven, simulation-based solution, the Simulated Cell™. Integration of omics data with a curated signaling network enables the accurate and interpretable prediction of 66,348 combination-cell line pairs obtained from a large-scale combinatorial drug sensitivity screen of 684 combinations across 97 cancer cell lines (BAC = 0.62, AUC = 0.7). We highlight drug combination pairs that interact with DNA Damage Response pathways and are predicted to be synergistic, and deep network insight to identify biomarkers driving combination synergy. We demonstrate that the cancer cell ‘avatars’ capture the biological complexity of their in vitro counterparts, enabling the identification of pathway-level mechanisms of combination benefit to guide clinical translatability.